| 6.60 Data as of May 22 | +0.30 / +4.76%Today’s Change | 4.30 Today|||52-Week Range 16.68 | -7.95% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +81.82% increase from the last price of 6.60.

The current consensus among 6 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




